Old Web
English
Sign In
Acemap
>
authorDetail
>
Ioannis Sapountzis
Ioannis Sapountzis
Boehringer Ingelheim
Growth inhibition
Autophosphorylation
Tyrosine kinase
Chemistry
Molecular biology
3
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype
2018
Ulrich Hirt
Irene Waizenegger
Norbert Schweifer
Christian Haslinger
Daniel Gerlach
Jürgen Braunger
Ulrike Weyer-Czernilofsky
Heinz Stadtmüller
Ioannis Sapountzis
Gerd Bader
Andreas Zoephel
Bojan Bister
Anke Baum
Jens Juergen Quant
Norbert Kraut
Pilar Garin-Chesa
Günther R. Adolf
Show All
Source
Cite
Save
Citations (26)
Abstract A249: BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer.
2011
Molecular Cancer Therapeutics
Ulrich Hirt
Juergen Braunger
Michael Schleicher
Ulrike Weyer-Czernilofsky
Pilar Garin-Chesa
Bojan Bister
Heinz Stadtmueller
Ioannis Sapountzis
Norbert Kraut
Guenther Adolf
Show All
Source
Cite
Save
Citations (11)
Dérivés de pyrimidine utilisables en tant qu'inhibiteurs de la protéine qu'est la tyrosine kinase 2
2010
Heinz Stadtmueller
Ioannis Sapountzis
Show All
Source
Cite
Save
Citations (0)
1